Literature DB >> 22171270

Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1.

Carolin A Guenzel1, Cécile Hérate, Erwann Le Rouzic, Priscilla Maidou-Peindara, Holly A Sadler, Marie-Christine Rouyez, Louis M Mansky, Serge Benichou.   

Abstract

The HIV-1 Vpr protein participates in the early steps of the virus life cycle by influencing the accuracy of reverse transcription. This role of Vpr was related to the recruitment of the nuclear form of the uracil DNA glycosylase (UNG2) enzyme into virus particles, but several conflicting findings have been reported regarding the role of UNG2 encapsidation on viral infectivity. Here, we report that the catalytic activity of UNG2 was not required for influencing HIV-1 mutation, and this function of UNG2 was mapped within a 60-amino-acid domain located in the N-terminal region of the protein required for direct interaction with the p32 subunit of the replication protein A (RPA) complex. Importantly, enforced recruitment of overexpressed UNG2 into virions resulted in a net increase of virus infectivity, and this positive effect on infectivity was also independent of the UNG2 enzymatic activity. In contrast, virus infectivity and replication, as well as the efficiency of the viral DNA synthesis, were significantly reduced when viruses were produced from cells depleted of either endogenous UNG2 or RPA p32. Taken together, these results demonstrate that incorporation of UNG2 into virions has a positive impact on HIV-1 infectivity and replication and positively influences the reverse transcription process through a nonenzymatic mechanism involving the p32 subunit of the RPA complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171270      PMCID: PMC3302282          DOI: 10.1128/JVI.05163-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Replication protein A 32 interacts through a similar binding interface with TIPIN, XPA, and UNG2.

Authors:  Seikh Imtiaz Ali; Jae-Sun Shin; Sung-Hun Bae; Byoungkook Kim; Byong-Seok Choi
Journal:  Int J Biochem Cell Biol       Date:  2010-04-22       Impact factor: 5.085

2.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

3.  X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells.

Authors:  Kate L Jones; Michael Roche; Michael P Gantier; Nasim A Begum; Tasuku Honjo; Salvatore Caradonna; Bryan R G Williams; Johnson Mak
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

4.  Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody.

Authors:  Jérôme Bouchet; Stéphane E Basmaciogullari; Pavel Chrobak; Bettina Stolp; Nathalie Bouchard; Oliver T Fackler; Patrick Chames; Paul Jolicoeur; Serge Benichou; Daniel Baty
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

5.  Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice.

Authors:  Frank S De Silva; Bernard Moss
Journal:  Virol J       Date:  2008-12-02       Impact factor: 4.099

6.  Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect.

Authors:  Christelle Langevin; Priscilla Maidou-Peindara; Per Arne Aas; Guillaume Jacquot; Marit Otterlei; Geir Slupphaug; Serge Benichou
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

7.  Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1.

Authors:  Marc-André Langlois; Michael S Neuberger
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

8.  Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44).

Authors:  Toril Ranneberg-Nilsen; Hege Avsnes Dale; Luisa Luna; Ragnhild Slettebakk; Ottar Sundheim; Halvor Rollag; Magnar Bjørås
Journal:  J Mol Biol       Date:  2008-05-17       Impact factor: 5.469

9.  Further evidence for involvement of a noncanonical function of uracil DNA glycosylase in class switch recombination.

Authors:  Nasim A Begum; Andre Stanlie; Tomomitsu Doi; Yoko Sasaki; Hai Wei Jin; Yong Sung Kim; Hitoshi Nagaoka; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

10.  Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA.

Authors:  Lars Hagen; Bodil Kavli; Mirta M L Sousa; Kathrin Torseth; Nina B Liabakk; Ottar Sundheim; Javier Pena-Diaz; Marit Otterlei; Ole Hørning; Ole N Jensen; Hans E Krokan; Geir Slupphaug
Journal:  EMBO J       Date:  2007-12-13       Impact factor: 11.598

View more
  16 in total

1.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells.

Authors:  Erik C Hansen; Monica Ransom; Jay R Hesselberth; Nina N Hosmane; Adam A Capoferri; Katherine M Bruner; Ross A Pollack; Hao Zhang; Michael Bradley Drummond; Janet M Siliciano; Robert Siliciano; James T Stivers
Journal:  Elife       Date:  2016-09-20       Impact factor: 8.140

Review 3.  Nature, nurture and HIV: The effect of producer cell on viral physiology.

Authors:  Sergey Iordanskiy; Steven Santos; Michael Bukrinsky
Journal:  Virology       Date:  2013-06-05       Impact factor: 3.616

4.  The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction.

Authors:  Ying Wu; Xiaohong Zhou; Christopher O Barnes; Maria DeLucia; Aina E Cohen; Angela M Gronenborn; Jinwoo Ahn; Guillermo Calero
Journal:  Nat Struct Mol Biol       Date:  2016-08-29       Impact factor: 15.369

5.  Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration.

Authors:  Amy F Weil; Devlina Ghosh; Yan Zhou; Lauren Seiple; Moira A McMahon; Adam M Spivak; Robert F Siliciano; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

6.  Differential regulation of S-region hypermutation and class-switch recombination by noncanonical functions of uracil DNA glycosylase.

Authors:  Ashraf S Yousif; Andre Stanlie; Samiran Mondal; Tasuku Honjo; Nasim A Begum
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

Review 7.  AID and Apobec3G haphazard deamination and mutational diversity.

Authors:  Malgorzata Jaszczur; Jeffrey G Bertram; Phuong Pham; Matthew D Scharff; Myron F Goodman
Journal:  Cell Mol Life Sci       Date:  2012-11-22       Impact factor: 9.261

8.  Staphylococcus aureus protein SAUGI acts as a uracil-DNA glycosylase inhibitor.

Authors:  Hao-Ching Wang; Kai-Cheng Hsu; Jinn-Moon Yang; Mao-Lun Wu; Tzu-Ping Ko; Shen-Rong Lin; Andrew H-J Wang
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

9.  Virus-producing cells determine the host protein profiles of HIV-1 virion cores.

Authors:  Steven Santos; Yuri Obukhov; Sergei Nekhai; Michael Bukrinsky; Sergey Iordanskiy
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

Review 10.  HIV-1 Vpr-a still "enigmatic multitasker".

Authors:  Carolin A Guenzel; Cécile Hérate; Serge Benichou
Journal:  Front Microbiol       Date:  2014-03-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.